Literature DB >> 26735626

Psoriatic arthritis: complexities, comorbidities and implications for the clinic.

Muhammad Haroon1, Oliver FitzGerald2,3.   

Abstract

Psoriatic arthritis (PsA) is a chronic immune-mediated inflammatory disease that affects peripheral joints, entheses and axial sites in addition to both skin and nails. There is considerable evidence to support the assertion that PsA is actually a multisystem disease. Contrary to earlier beliefs, PsA is not only common but also a potentially deforming and disabling disease. In addition to the characteristic extra-articular features, such as uveitis and inflammatory bowel disease, patients with PsA may also suffer from co-existing diseases, referred to as comorbidities. The presence of both extra-articular manifestations and comorbidities may have consequences for the treatment, prognosis and outcome of the disease, which frequently go unrecognized or undertreated. The following review article describes the complexities and comorbidities of PsA as well as their implications for the clinic.

Entities:  

Keywords:  comorbidities; psoriatic arthritis; treatment

Mesh:

Year:  2016        PMID: 26735626     DOI: 10.1586/1744666X.2016.1139453

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  9 in total

Review 1.  Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease.

Authors:  Holly Anderton; Ian P Wicks; John Silke
Journal:  Nat Rev Rheumatol       Date:  2020-07-08       Impact factor: 20.543

2.  Natural Compounds for the Treatment of Psoriatic Arthritis: A Proposal Based on Multi-Targeted Osteoclastic Regulation and on a Preclinical Study.

Authors:  Shiqiang Deng; Jianwen Cheng; Jinmin Zhao; Felix Yao; Jiake Xu
Journal:  JMIR Res Protoc       Date:  2017-07-11

3.  KIF3A and IL-4 are disease-specific biomarkers for psoriatic arthritis susceptibility.

Authors:  Raffaella Cascella; Claudia Strafella; Michele Ragazzo; Laura Manzo; Gaetana Costanza; John Bowes; Ulrike Hüffmeier; Saverio Potenza; Federica Sangiuolo; André Reis; Anne Barton; Giuseppe Novelli; Augusto Orlandi; Emiliano Giardina
Journal:  Oncotarget       Date:  2017-09-08

Review 4.  Mitigation of disease- and treatment-related risks in patients with psoriatic arthritis.

Authors:  Martin Bergman; Amy Lundholm
Journal:  Arthritis Res Ther       Date:  2017-03-20       Impact factor: 5.156

5.  Patterns of clinical nail appearances in patients with cutaneous psoriasis.

Authors:  Elena Mihaela Marina; Carolina Botar-Jid; Sorana Daniela Bolboaca; Iulia Ioana Roman; Corina Simona Senila; Carmen Mihaela Mihu; Dumitru Alexandru Tataru
Journal:  Clujul Med       Date:  2017-01-15

6.  TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA).

Authors:  Nienke J Kleinrensink; Frank T Perton; Juliëtte N Pouw; Nanette L A Vincken; Sarita A Y Hartgring; Mylène P Jansen; Saeed Arbabi; Wouter Foppen; Pim A de Jong; Janneke Tekstra; Emmerik F A Leijten; Julia Spierings; Floris P J G Lafeber; Paco M J Welsing; Marloes W Heijstek
Journal:  BMJ Open       Date:  2022-10-10       Impact factor: 3.006

7.  Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis.

Authors:  Agnes Szentpetery; Eric Heffernan; Martina Gogarty; Lisa Mellerick; Janet McCormack; Muhammad Haroon; Musaab Elmamoun; Phil Gallagher; Genevieve Kelly; Aurelie Fabre; Brian Kirby; Oliver FitzGerald
Journal:  Arthritis Res Ther       Date:  2017-07-05       Impact factor: 5.156

8.  Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry.

Authors:  Proton Rahman; Regan Arendse; Majed Khraishi; Dalton Sholter; Maqbool Sheriff; Emmanouil Rampakakis; Allen J Lehman; Francois Nantel
Journal:  BMJ Open       Date:  2020-08-13       Impact factor: 2.692

9.  Fostering Interprofessional Patient-centred Collaboration in Healthcare through CPD: Our Learnings from the PARTNER Programme.

Authors:  Loh Wei Qi; Audra Barclay; Tina Garcia; Lisa Sullivan
Journal:  J Eur CME       Date:  2020-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.